Inventor · disambiguated record
Alberto Bardelli
Also filed as: BARDELLI ALBERTO
9 granted patents·11 pending applications·22 citations·filing 1997–2021
82Inventor score
Files withBARDELLI ALBERTO5UNIV JOHNS HOPKINS4SIENA SALVATORE3AMGEN1FUNDACIO INST MAR DINVESTIGACIONS MEDIQUES IMIM1
Top patents by PatentIndex Score
20 records- 0176US7745165B2Phosphatase associated with metastasisUNIV JOHNS HOPKINS·Filed 2004·Granted Jun 29, 2010·4 cites·19 claims
- 0276US7635570B2Epidermal growth factor receptor gene copy numberSIENA SALVATORE·Filed 2006·Granted Dec 22, 2009·13 cites·19 claims
- 0363US9926606B2Tyrosine kinomeUNIV JOHNS HOPKINS·Filed 2015·Granted Mar 27, 2018·0 cites·6 claims
- 0461US9206467B2Tyrosine kinomeUNIV JOHNS HOPKINS·Filed 2013·Granted Dec 8, 2015·0 cites·28 claims
- 0553US9580750B2P13K pathway mutations in cancerPARSONS DONALD WILLIAM·Filed 2006·Granted Feb 28, 2017·1 cites·13 claims
- 0649US2016095920A1Kras mutations and resistance to anti-egfr treatmentSLOAN KETTERING INST CANCER·Filed 2015·Application pending·0 cites
- 0749US2007037150A1Tyrosine kinomeUNIV JOHNS HOPKINS·Filed 2004·Application pending·0 cites
- 0849US2017198353A1Kras mutations and resistance to anti-egfr treatmentMEMORIAL SLOAN- KETTERING CANCER INST·Filed 2016·Application pending·0 cites
- 0948US2021262037A1Methods of treating cancer based on identifying mutations in the extracellular domain iii of epidermal growth factor receptor geneBARDELLI ALBERTO·Filed 2021·Application pending·0 cites
- 1047US8394598B2Tyrosine kinomeBARDELLI ALBERTO·Filed 2010·Granted Mar 12, 2013·0 cites·8 claims
- 1146US2014134158A1Kras mutations and resistance to anti-egfr treatmentBARDELLI ALBERTO·Filed 2013·Application pending·0 cites
- 1244US2009075267A1K-ras and B-raf mutations and anti-EGFr antibody therapySIENA SALVATORE·Filed 2008·Application pending·0 cites
- 1343US11015225B2Method of treating cancer based on identifying mutations in the extracellular domain III of epidermal growth factor receptor geneFUNDACIO INST MAR DINVESTIGACIONS MEDIQUES IMIM·Filed 2014·Granted May 25, 2021·0 cites·12 claims
- 1442US6245742B1Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic usePHARMACIA & UPJOHN SPA·Filed 1997·Granted Jun 12, 2001·4 cites·33 claims
- 1541US2009269344A1Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissuesSIENA SALVATORE·Filed 2006·Application pending·0 cites
- 1638US2012115896A1Isogenic human cell lines comprising mutated cancer alleles and process using the cell linesBARDELLI ALBERTO·Filed 2008·Application pending·0 cites
- 1737US2011212456A1K-ras and B-raf mutations and anti-EGFr antibody therapyAMGEN·Filed 2010·Application pending·0 cites
- 1835US9127319B2MLK4 gene, a new diagnostic and prognostic marker in cancersBARDELLI ALBERTO·Filed 2010·Granted Sep 8, 2015·0 cites·10 claims
- 1933US2021275630A1Inactivation of dna repair as an anticancer therapyPHOREMOST LTD·Filed 2017·Application pending·0 cites
- 2030US2016311908A1Methods of treating patients having mutations in the extracellular domain of epidermal growth factor receptor (egfr) with a combination of three fully human monoclonal anti-egfr antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alberto Bardelli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →